ZA983452B - Substituted pyrrolopyridines useful in the treatment of inflammatory diseases. - Google Patents
Substituted pyrrolopyridines useful in the treatment of inflammatory diseases.Info
- Publication number
- ZA983452B ZA983452B ZA9803452A ZA983452A ZA983452B ZA 983452 B ZA983452 B ZA 983452B ZA 9803452 A ZA9803452 A ZA 9803452A ZA 983452 A ZA983452 A ZA 983452A ZA 983452 B ZA983452 B ZA 983452B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- inflammatory diseases
- useful
- substituted pyrrolopyridines
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4424497P | 1997-04-24 | 1997-04-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA983452B true ZA983452B (en) | 1999-10-25 |
Family
ID=21931293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9803452A ZA983452B (en) | 1997-04-24 | 1998-04-23 | Substituted pyrrolopyridines useful in the treatment of inflammatory diseases. |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR012593A1 (es) |
AU (1) | AU7132998A (es) |
WO (1) | WO1998047899A1 (es) |
ZA (1) | ZA983452B (es) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6166048A (en) * | 1999-04-20 | 2000-12-26 | Targacept, Inc. | Pharmaceutical compositions for inhibition of cytokine production and secretion |
DK0948495T3 (da) | 1996-11-19 | 2004-06-01 | Amgen Inc | Aryl- og heteroarylsubstitueret, kondenseret pyrrol som antiinflammatoriske midler |
WO1999020624A1 (en) | 1997-10-20 | 1999-04-29 | F.Hoffmann-La Roche Ag | Bicyclic kinase inhibitors |
HUP0004947A2 (hu) * | 1997-11-14 | 2002-03-28 | Sankyo Co., Ltd. | Piridilpirrol-származékok |
AU4694999A (en) * | 1998-08-06 | 2000-02-28 | Warner-Lambert Company | Use of thiazolidinedione derivatives for the treatment or prevention of cataracts |
CA2346665A1 (en) | 1998-10-07 | 2000-04-13 | Smithkline Beecham Corporation | Novel treatment for stroke management |
ATE258055T1 (de) | 1998-11-04 | 2004-02-15 | Smithkline Beecham Corp | Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine |
WO2001030778A1 (en) * | 1999-10-27 | 2001-05-03 | Novartis Ag | Thiazole and imidazo [4,5-b] pyridine compounds and their pharmaceutical use |
CZ301750B6 (cs) * | 1999-12-24 | 2010-06-09 | Aventis Pharma Limited | Bicyklický pyrrolový derivát, jeho použití pri výrobe léciva, farmaceutická kompozice tento derivát obsahující a pro použití pri lécení |
GB9930698D0 (en) * | 1999-12-24 | 2000-02-16 | Rhone Poulenc Rorer Ltd | Chemical compounds |
WO2001057018A1 (en) * | 2000-02-02 | 2001-08-09 | Abbott Laboratories | Azaazulene inhibitors of p38 map kinase and tnf-alpha |
PE20020506A1 (es) * | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
GB0115109D0 (en) * | 2001-06-21 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
KR20040111445A (ko) | 2002-03-28 | 2004-12-31 | 에자이 가부시키가이샤 | 신경퇴행성 질환 치료용 c─Jun N─말단 키나아제억제제로서의 7─아자인돌 |
SG135051A1 (en) * | 2002-06-20 | 2007-09-28 | Aventis Pharma Ltd | Azaindoles |
ATE349210T1 (de) | 2002-07-09 | 2007-01-15 | Boehringer Ingelheim Pharma | Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege |
GB0305142D0 (en) | 2003-03-06 | 2003-04-09 | Eisai London Res Lab Ltd | Synthesis |
EP2295433A3 (en) * | 2003-03-06 | 2011-07-06 | Eisai R&D Management Co., Ltd. | JNK inhibitors |
EP1628975A2 (en) | 2003-05-16 | 2006-03-01 | Eisai Co., Ltd. | Jnk inhibitors |
AU2004293018B2 (en) * | 2003-11-19 | 2010-02-18 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
PT1696920E (pt) | 2003-12-19 | 2015-01-14 | Plexxikon Inc | Compostos e métodos para o desenvolvimento de moduladores de ret |
GB0405055D0 (en) * | 2004-03-05 | 2004-04-07 | Eisai London Res Lab Ltd | JNK inhibitors |
US7498342B2 (en) | 2004-06-17 | 2009-03-03 | Plexxikon, Inc. | Compounds modulating c-kit activity |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
EP1676574A3 (en) | 2004-12-30 | 2006-07-26 | Johnson & Johnson Vision Care, Inc. | Methods for promoting survival of transplanted tissues and cells |
BRPI0610828A2 (pt) * | 2005-05-16 | 2010-07-27 | Irm Llc | compostos e composições como inibidores de proteìna quinase |
GB0516156D0 (en) | 2005-08-05 | 2005-09-14 | Eisai London Res Lab Ltd | JNK inhibitors |
EP1953148B1 (en) | 2005-10-28 | 2012-02-29 | Takeda Pharmaceutical Company Limited | Heterocyclic amide compound and use thereof |
CL2007002617A1 (es) | 2006-09-11 | 2008-05-16 | Sanofi Aventis | Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto. |
WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
WO2009012283A1 (en) | 2007-07-17 | 2009-01-22 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
CN104530052A (zh) * | 2008-06-10 | 2015-04-22 | 普莱希科公司 | 用于激酶调节的5h-吡咯[2,3-b]吡嗪衍生物和其适应症 |
MX349923B (es) | 2009-04-03 | 2017-08-21 | Hoffmann La Roche | Composiciones del ácido propano-1-sulfónico {3-[5-(4-cloro-fenil)- 1h-pirrolo [2,3-b]-piridina-3-carbonil]-2,4-difluoro-fenil]-amida y el uso de las mismas. |
ES2633317T3 (es) | 2009-11-06 | 2017-09-20 | Plexxikon, Inc. | Compuestos y métodos para la modulación de quinasas, e indicaciones para ello |
PT2672967T (pt) | 2011-02-07 | 2018-12-07 | Plexxikon Inc | Compostos e métodos de modulação da quinase e suas indicações |
AR085279A1 (es) | 2011-02-21 | 2013-09-18 | Plexxikon Inc | Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico |
US20130158049A1 (en) * | 2011-12-20 | 2013-06-20 | Hoffmann-La Roche Inc. | 7-azaindole inhibitors of crac |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
FR3001219A1 (fr) * | 2013-01-22 | 2014-07-25 | Centre Nat Rech Scient | Inhibiteurs de kinases |
WO2017064216A1 (en) * | 2015-10-13 | 2017-04-20 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | N1- and n7-substituted sibiriline derivatives and their use as inhibitor of cellular necroptosis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0871444A4 (en) * | 1995-08-10 | 1999-01-13 | Merck & Co Inc | 2.5 SUBSTITUTED ARYL PYRROL, THE COMPOSITIONS THAT CONTAIN AND THE USE THEREOF |
-
1998
- 1998-04-17 AU AU71329/98A patent/AU7132998A/en not_active Abandoned
- 1998-04-17 WO PCT/US1998/007831 patent/WO1998047899A1/en active Application Filing
- 1998-04-23 ZA ZA9803452A patent/ZA983452B/xx unknown
- 1998-04-23 AR ARP980101885A patent/AR012593A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU7132998A (en) | 1998-11-13 |
WO1998047899A1 (en) | 1998-10-29 |
AR012593A1 (es) | 2000-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA983452B (en) | Substituted pyrrolopyridines useful in the treatment of inflammatory diseases. | |
ZA983451B (en) | Substituted imidazoles useful in the treatment of inflammatory diseases. | |
IL142908A0 (en) | Compounds useful in the treatment of inflammatory diseases | |
IL133766A0 (en) | 2-substituted imidazoles useful in the treatment of inflammatory diseases | |
MXPA03002813A (es) | Compuestos utiles en el tratamiento de enfermedades inflamatorias. | |
NO974595D0 (no) | Imidazo£1,2-a|pyridin-derivater | |
ZA9711029B (en) | Therapeutic agents. | |
DE69529777D1 (de) | 2-Benzylthio-8-amino(1,2,4)triazolo(1,5-a)pyridine | |
EP0777474A4 (en) | METHOD FOR TREATING INFLAMMABLE JOINT DISEASES | |
IL139589A0 (en) | Use of cyclosporins in the treatment of inflammatory autoimmune diseases | |
ZA984174B (en) | Novel triptolide derivatives useful in the treatment of autoimmune diseases | |
GB9816234D0 (en) | Compounds for use in the treatment of inflammation | |
HK1025954A1 (en) | Triptolide derivatives useful in the treatment of autoimmune diseases | |
IL129460A0 (en) | Use of lofexidine in the treatment of behavioral disorders | |
ZA985818B (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders. | |
AU7639998A (en) | Pyrrolo{2,1,5-cd}indolizine derivatives useful in the prevention or treatment ofestrogen related diseases or syndromes | |
AU3838695A (en) | Use of the bio-spectrum in animal embryo-engineering | |
AU2002300624A1 (en) | Substituted imidazoles useful in the treatment of inflammatory diseases | |
SI0983275T1 (en) | Novel triptolide derivatives useful in the treatment of autoimmune diseases | |
AU2002306210A1 (en) | 2-substituted imidazoles useful in the treatment of inflammatory diseases | |
SI0966447T1 (en) | Small molecules useful in the treatment of inflammatory disease | |
ZA987065B (en) | Small molecules useful in the treatment of inflammatory disease. | |
GB9816352D0 (en) | The treatment of inflammatory disorders | |
GB9816349D0 (en) | The treatment of inflammatory disorders | |
AU7639898A (en) | Pyrrolo{2,1,5-cd}indolizine derivatives useful in the prevention or treat ment ofestrogen related diseases or syndromes |